Advertisement
Screener

INTEGRATED BIOPHARMA INC (INBP) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

2.0 / 5 stars · 47/116 Roast Me

INTEGRATED BIOPHARMA INC Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

INTEGRATED BIOPHARMA INC (INBP) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.

Financial Statements › Notes

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-05-08

  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 361.73K shares, a 34.28% decline year-over-year.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-03-31 was 1.21M shares, a 88.31% increase year-over-year.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 872.72K shares, a 8.05% increase from fiscal 2024.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 807.68K shares.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
  • INTEGRATED BIOPHARMA INC incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 2.48M shares, a 2.62% increase from fiscal 2021.
Period endIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month
2026-03-310.00 shares
10-Q · filed 2026-05-08
0.00 shares
10-Q · filed 2026-05-08
2025-12-310.00 shares
10-Q · filed 2026-02-11
0.00 shares
10-Q · filed 2026-02-11
2025-09-30361.73K shares
10-Q · filed 2025-11-10
2025-06-30872.72K shares
10-K · filed 2025-09-23
2025-03-311.21M shares
10-Q · filed 2026-05-08
770.05K shares
10-Q · filed 2026-05-08
2024-12-311.13M shares
10-Q · filed 2026-02-11
673.26K shares
10-Q · filed 2026-02-11
2024-09-30550.37K shares
10-Q · filed 2025-11-10
2024-06-30807.68K shares
10-K · filed 2025-09-23
2024-03-31644.61K shares
10-Q · filed 2025-05-14
664.61K shares
10-Q · filed 2024-05-10
0.00 shares
10-Q · filed 2025-05-14
2023-12-310.00 shares
10-Q · filed 2025-02-13
0.00 shares
10-Q · filed 2025-02-13
2023-09-300.00 shares
10-Q · filed 2024-11-13
2023-06-300.00 shares
10-K · filed 2024-09-20
2023-03-311.51M shares
10-Q · filed 2024-05-10
0.00 shares
10-Q · filed 2024-05-10
2022-12-310.00 shares
10-Q · filed 2023-02-10
0.00 shares
10-Q · filed 2023-02-10
2022-09-300.00 shares
10-Q · filed 2022-11-10
2022-06-302.48M shares
10-K · filed 2023-09-15
2022-03-312.54M shares
10-Q · filed 2023-05-11
2.59M shares
10-Q · filed 2023-05-11
2021-12-312.62M shares
10-Q · filed 2023-02-10
2.62M shares
10-Q · filed 2023-02-10
2021-09-302.78M shares
10-Q · filed 2022-11-10
2021-06-302.41M shares
10-K · filed 2022-09-13
2021-03-313.15M shares
10-Q · filed 2021-05-13
2.77M shares
10-Q · filed 2021-05-13
2020-12-312.44M shares
10-Q · filed 2022-02-10
2.31M shares
10-Q · filed 2022-02-10
2020-09-302.15M shares
10-Q · filed 2021-11-10
2020-06-301.58M shares
10-K · filed 2021-09-02
2020-03-311.32M shares
10-Q · filed 2021-05-13
1.11M shares
10-Q · filed 2021-05-13
2019-12-311.03M shares
10-Q · filed 2021-02-12
1.04M shares
10-Q · filed 2021-02-12
2019-09-301.16M shares
10-Q · filed 2020-11-12
2019-06-30656.05K shares
10-K · filed 2020-09-23
2019-03-31542.78K shares
10-Q · filed 2020-05-13
582.52K shares
10-Q · filed 2020-05-13
2018-12-31506.33K shares
10-Q · filed 2020-02-12
600.84K shares
10-Q · filed 2020-02-12
2018-09-30744.82K shares
10-Q · filed 2019-11-13
2018-06-30951.40K shares
10-K · filed 2019-08-29
2018-03-31836.43K shares
10-Q · filed 2019-05-15
2017-06-30825.89K shares
10-K · filed 2018-09-12
2017-03-311.43M shares
10-Q · filed 2018-05-09
856.93K shares
10-Q · filed 2017-05-10
856.93K shares
10-Q · filed 2018-05-09
2016-12-31567.96K shares
10-Q · filed 2017-02-10
2016-09-3077.71K shares
10-Q · filed 2017-11-09
2016-06-3085.89K shares
10-K · filed 2017-09-01
2016-03-31176.75K shares
10-Q · filed 2017-05-10
92.53K shares
10-Q · filed 2017-05-10
2015-09-3050.04K shares
10-Q · filed 2016-11-10
2015-06-3049.94K shares
10-K · filed 2016-09-02
2015-03-3166.59K shares
10-Q · filed 2016-05-13
2014-12-3199.89K shares
10-Q · filed 2016-02-19
2014-09-30199.78K shares
10-Q · filed 2015-11-05
2014-06-30111.86K shares
10-K · filed 2015-09-04
2014-03-3179.75K shares
10-Q · filed 2015-05-14
2013-12-3173.01K shares
10-Q · filed 2015-02-17
37.02K shares
10-Q · filed 2015-02-17
2013-09-3089.86K shares
10-Q · filed 2014-11-07
2013-06-30163.46K shares
10-K · filed 2014-09-08